Prisma Health University Medical Group
Prisma Health University Medical Group was paid $172.15M by Medicaid between Jan 2018 and Dec 2024, across 297 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
GREENVILLE, SC 29607
Next to other Internal Medicine Physician providers in South Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 433,032 | $22.87M | |
| 2019 | 411,524 | $22.76M | |
| 2020 | 366,215 | $21.28M | |
| 2021 | 444,347 | $25.42M | |
| 2022 | 468,899 | $27.72M | |
| 2023 | 464,681 | $27.60M | |
| 2024incomplete | 446,774 | $24.51M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 521,591 | 494,897 | $37.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 672,376 | 630,263 | $33.86M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.6% | 181,478 | 178,547 | $14.83M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.1% | 68,610 | 63,796 | $7.06M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 4.0% | 6,405 | 5,888 | $6.92M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 59,213 | 57,814 | $6.64M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.4% | 129,841 | 127,906 | $5.89M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 74,791 | 70,077 | $5.36M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 65,459 | 64,906 | $5.11M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 140,066 | 138,088 | $3.97M |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.1% | 23,042 | 22,817 | $3.63M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.6% | 30,638 | 27,754 | $2.71M |
285 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 32,407 | $2.50M |
| G9153 | Mapcp demonstration - physician incentive pool | 1.3% | 40,768 | $2.19M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.1% | 12,748 | $1.91M |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.1% | 27,009 | $1.84M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 17,540 | $1.60M |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 20,711 | $1.58M |
| 99243 | <1% | 14,293 | $1.52M | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 33,129 | $1.50M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 8,733 | $1.35M |
| 95812 | <1% | 5,913 | $1.30M | |
| 59514 | <1% | 1,155 | $1.11M | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 8,892 | $1.03M |
| 90461 | <1% | 42,092 | $863K | |
| 87428 | <1% | 13,118 | $812K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 13,068 | $771K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 9,097 | $760K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 7,310 | $582K |
| 76820 | <1% | 14,262 | $536K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 39,121 | $528K |
| 99080 | <1% | 2,560 | $511K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 61,162 | $436K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 4,203 | $431K |
| 76801 | <1% | 4,163 | $424K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 5,050 | $420K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 3,791 | $420K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 4,525 | $419K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 5,177 | $393K |
| 99460 | <1% | 5,059 | $389K | |
| 59025 | Fetal non-stress test | <1% | 14,780 | $365K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14,091 | $352K |
| 93320 | <1% | 8,683 | $351K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 3,573 | $341K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 4,341 | $322K |
| 93304 | <1% | 3,370 | $304K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,549 | $284K |
| 93325 | <1% | 16,079 | $283K | |
| 99188 | <1% | 19,046 | $280K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 59,469 | $270K |
| 99223 | Prolong inpt eval add15 m | <1% | 2,198 | $269K |
| 94010 | <1% | 10,708 | $255K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,780 | $235K |
| 93000 | <1% | 16,267 | $232K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16,885 | $230K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 7,542 | $218K |
| 95782 | <1% | 2,033 | $206K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 2,032 | $200K |
| 01922 | <1% | 935 | $171K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 287 | $164K |
| 99245 | <1% | 779 | $164K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,991 | $156K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,498 | $143K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,066 | $142K |
| 59430 | <1% | 1,493 | $141K | |
| 0001A | <1% | 3,587 | $138K | |
| 0002A | <1% | 3,404 | $135K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 585 | $123K |
| 31575 | <1% | 1,913 | $121K | |
| 92015 | Determination of refractive state | <1% | 6,961 | $120K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 14,928 | $120K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,967 | $116K |
| 99242 | <1% | 1,424 | $112K | |
| 99051 | <1% | 9,704 | $112K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,406 | $111K |
| 81002 | <1% | 34,338 | $110K | |
| 54150 | <1% | 1,421 | $109K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,787 | $109K |
| 99221 | <1% | 1,332 | $108K | |
| 96127 | <1% | 16,276 | $107K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,106 | $103K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,461 | $101K |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,168 | $92K |
| 97803 | <1% | 3,750 | $85K | |
| 93321 | <1% | 4,940 | $82K | |
| 73100 | <1% | 3,244 | $82K | |
| 92567 | <1% | 4,865 | $75K | |
| 99205 | Prolong outpt/office vis | <1% | 550 | $73K |
| 99220 | <1% | 455 | $68K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,339 | $67K |
| 20610 | <1% | 2,731 | $67K | |
| 81003 | <1% | 24,939 | $64K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 895 | $64K |
| 92588 | <1% | 1,194 | $62K | |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 2,385 | $60K |
| 99462 | <1% | 1,776 | $58K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 324 | $57K |
| 97802 | <1% | 1,210 | $50K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,352 | $50K |
| 99078 | <1% | 1,622 | $49K | |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 117 | $47K |
| 85018 | <1% | 18,232 | $44K | |
| 76818 | <1% | 523 | $44K | |
| 82947 | <1% | 12,912 | $43K | |
| 99219 | <1% | 433 | $42K | |
| 11750 | <1% | 397 | $42K | |
| 96160 | <1% | 3,266 | $39K | |
| 95811 | <1% | 428 | $38K | |
| 99235 | <1% | 282 | $38K | |
| 72082 | <1% | 593 | $36K | |
| 92557 | <1% | 1,106 | $36K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 600 | $35K |
| 76821 | <1% | 512 | $34K | |
| 99417 | Prolong home eval add 15m | <1% | 1,111 | $34K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 690 | $32K |
| 99441 | <1% | 2,191 | $32K | |
| 90677 | <1% | 1,931 | $31K | |
| 92579 | <1% | 743 | $31K | |
| 73070 | <1% | 1,337 | $29K | |
| 99442 | <1% | 1,247 | $28K | |
| 95117 | <1% | 3,747 | $27K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,239 | $26K |
| 73630 | <1% | 1,227 | $24K | |
| 31622 | <1% | 483 | $24K | |
| 0071A | <1% | 573 | $23K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,643 | $23K |
| 92587 | <1% | 486 | $23K | |
| 81025 | <1% | 3,470 | $23K | |
| 17110 | <1% | 341 | $21K | |
| 0072A | <1% | 516 | $21K | |
| 87807 | <1% | 1,796 | $20K | |
| 90686 | <1% | 22,456 | $20K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,231 | $19K |
| 93296 | <1% | 1,891 | $17K | |
| 95819 | <1% | 224 | $17K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 229 | $16K |
| G9011 | Coordinated care fee, risk adjusted maintenance, level 5 | <1% | 186 | $16K |
| 99174 | <1% | 3,028 | $16K | |
| 31231 | <1% | 114 | $15K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 111 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,112 | $14K |
| 72081 | <1% | 357 | $13K | |
| 72170 | <1% | 604 | $13K | |
| 51784 | <1% | 226 | $12K | |
| 90697 | <1% | 1,404 | $11K | |
| 73560 | <1% | 424 | $11K | |
| 95951 | <1% | 73 | $10K | |
| 42975 | <1% | 122 | $10K | |
| 93297 | <1% | 739 | $10K | |
| 0004A | <1% | 242 | $10K | |
| 93971 | <1% | 802 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 703 | $9K |
| 11721 | <1% | 308 | $9K | |
| 99234 | <1% | 79 | $9K | |
| 92201 | <1% | 426 | $9K | |
| 29075 | <1% | 138 | $9K | |
| 64615 | <1% | 101 | $8K | |
| 92002 | <1% | 184 | $8K | |
| 99255 | <1% | 38 | $8K | |
| 54161 | <1% | 68 | $8K | |
| 51798 | <1% | 1,107 | $8K | |
| 95806 | <1% | 239 | $8K | |
| J0475 | Injection, baclofen, 10 mg | <1% | 18 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,017 | $8K |
| 73090 | <1% | 326 | $7K | |
| 95251 | <1% | 446 | $7K | |
| 99381 | <1% | 79 | $7K | |
| 99217 | <1% | 121 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 995 | $7K |
| 96161 | <1% | 992 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,465 | $6K |
| 93295 | <1% | 316 | $6K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 261 | $5K |
| 76981 | <1% | 111 | $5K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 223 | $5K |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 171 | $5K |
| 99292 | <1% | 34 | $5K | |
| 92504 | <1% | 334 | $5K | |
| 87081 | <1% | 828 | $5K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 548 | $5K |
| 99443 | <1% | 156 | $5K | |
| 76825 | <1% | 28 | $5K | |
| 73610 | <1% | 246 | $5K | |
| 31526 | <1% | 67 | $5K | |
| 99253 | <1% | 39 | $5K | |
| 95886 | <1% | 97 | $4K | |
| 74018 | <1% | 315 | $4K | |
| 92551 | <1% | 891 | $4K | |
| 99241 | <1% | 105 | $4K | |
| 11981 | <1% | 82 | $4K | |
| 95816 | <1% | 78 | $4K | |
| 95720 | <1% | 19 | $4K | |
| 98966 | <1% | 318 | $4K | |
| 99170 | <1% | 38 | $4K | |
| 92552 | <1% | 268 | $3K | |
| 77073 | <1% | 123 | $3K | |
| 73564 | <1% | 176 | $3K | |
| 29065 | <1% | 52 | $3K | |
| 69210 | <1% | 118 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 29 | $3K |
| 99310 | Prolong nursin fac eval 15m | <1% | 91 | $3K |
| 99236 | Prolong inpt eval add15 m | <1% | 15 | $3K |
| 73590 | <1% | 133 | $3K | |
| 93298 | <1% | 229 | $3K | |
| 80076 | <1% | 392 | $2K | |
| 87210 | <1% | 505 | $2K | |
| 95885 | <1% | 74 | $2K | |
| 93308 | <1% | 48 | $2K | |
| 93922 | <1% | 440 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 26 | $2K |
| 94375 | <1% | 68 | $2K | |
| 93227 | <1% | 102 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 25 | $2K |
| 93016 | <1% | 158 | $2K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 169 | $2K |
| 0031A | <1% | 61 | $2K | |
| 95012 | <1% | 134 | $2K | |
| 90715 | <1% | 545 | $1K | |
| 90656 | <1% | 2,803 | $1K | |
| 51741 | <1% | 126 | $1K | |
| 73030 | <1% | 139 | $1K | |
| 97597 | <1% | 158 | $1K | |
| 90682 | <1% | 28 | $1K | |
| 62370 | <1% | 40 | $1K | |
| 93925 | <1% | 88 | $1K | |
| 42830 | <1% | 13 | $1K | |
| 94729 | <1% | 70 | $1K | |
| 93018 | <1% | 158 | $1K | |
| 99383 | <1% | 12 | $1K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 37 | $1K |
| 93294 | <1% | 107 | $953.75 | |
| 90651 | <1% | 712 | $920.88 | |
| 92555 | <1% | 104 | $920.53 | |
| 93970 | <1% | 76 | $877.66 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 15 | $833.84 |
| 99318 | <1% | 19 | $781.52 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 26 | $777.42 |
| 92582 | <1% | 20 | $777.27 | |
| 91200 | <1% | 64 | $746.86 | |
| 20611 | <1% | 33 | $728.18 | |
| 93272 | <1% | 46 | $698.35 | |
| 73000 | <1% | 28 | $668.64 | |
| 73502 | <1% | 42 | $656.68 | |
| 11102 | <1% | 12 | $635.40 | |
| 93886 | <1% | 14 | $607.48 | |
| V2020 | Frames, purchases | <1% | 14 | $590.10 |
| 58300 | <1% | 12 | $579.21 | |
| 17250 | <1% | 13 | $552.85 | |
| 96380 | <1% | 29 | $537.82 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 17 | $526.98 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 65 | $512.33 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $505.11 |
| 93280 | <1% | 27 | $462.18 | |
| 99307 | <1% | 41 | $457.96 | |
| 94060 | <1% | 29 | $406.48 | |
| 93228 | <1% | 43 | $380.15 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 28 | $335.97 |
| 85027 | <1% | 65 | $324.78 | |
| 73140 | <1% | 19 | $303.69 | |
| 94727 | <1% | 29 | $298.61 | |
| 93880 | <1% | 26 | $283.76 | |
| 99406 | <1% | 27 | $263.13 | |
| 92133 | <1% | 13 | $260.39 | |
| 83986 | <1% | 91 | $251.37 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 36 | $234.80 |
| 73562 | <1% | 14 | $180.24 | |
| 3074F | <1% | 22,159 | $148.17 | |
| 3078F | <1% | 20,126 | $136.22 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $127.94 |
| 80047 | <1% | 12 | $110.39 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12 | $103.45 |
| 90680 | <1% | 2,986 | $100.90 | |
| 93979 | <1% | 14 | $87.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 152 | $66.76 |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 12 | $61.30 |
| 99152 | <1% | 12 | $61.14 | |
| 81001 | <1% | 40 | $40.08 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 12 | $20.85 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $6.10 |
| 36416 | <1% | 394 | $2.69 | |
| 90685 | <1% | 659 | $1.33 | |
| 90619 | <1% | 86 | $0.41 | |
| 3079F | <1% | 102 | $0.33 | |
| 3044F | <1% | 49 | $0.24 | |
| 90381 | <1% | 27 | $0.11 | |
| 90670 | <1% | 7,411 | $0.09 | |
| 3075F | <1% | 27 | $0.05 | |
| 90698 | <1% | 4,925 | $0.04 | |
| 90633 | <1% | 1,020 | $0.03 | |
| 90744 | 0% | 742 | $0.00 | |
| 90696 | 0% | 26 | $0.00 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 0% | 17 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 279 | $0.00 |
| 90734 | 0% | 168 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 45 | $0.00 |
| 90672 | 0% | 14 | $0.00 | |
| 3077F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.